Waters Corporation (WAT)

Overall impact
B (67)

Commentary

Waters is a strong overall performer. With a 'B' rating of 67.5 for overall impact (78th percentile compared to all companies), Waters ranks 48th out of 103 industry peers, behind MyMD Pharmaceuticals, Alphatec, electroCore and 44 others, and ahead of Biolase, Silk Road Medical, Tandem Diabetes Care and 52 others. On top material causes for Waters's industry (Healthcare Equipment), Waters performs well in Child and Maternal Health (83.3 score), Sustainable Use of Natural Resources (95.4), Child and Maternal Health (92.6) and 6 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (18.8 score), Conflict Free Mineral Production (20.9), Technology Innovation (0.0) and 1 other cause where it received a 'D' or 'F' score.
Impact
Cause WAT
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1958
Employees
16,000
Sector
Health Care
Industry
Life Sciences Tools & Services
Sub-industry
Life Sciences Tools & Services
SASB industry
Medical Equipment & Supplies
Headquarters
Ma, United States
Share classes
WAT
Mission
Create business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, water quality, consumer products, and high value-added chemicals.
Description
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology used in drug discovery and development, comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Material causes
Ethos considers the following causes material for Waters Corporation, based on its industry sub-industry Life Sciences Tools & Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.